CIP2A and breast cancer: As shown in Supplement Figure S6, Elk1 and CIP2A showed higher mRNA expression in tumor versus adjacent normal tissue from all breast cancer patient samples, from paired tumor/normal tissue and from the TNBC subpopulation.